Two abstracts presented at the American Thoracic Society 2024 International Conference analyzed the phase 3 LIBERTY COPD BOREAS trial, finding that dupilumab improves pre- and post-bronchodilator lung ...
"Pre- and post-surgical immunotherapy improves outcomes for patients with operable lung cancer." ScienceDaily. www.sciencedaily.com / releases / 2024 / 05 / 240515224836.htm (accessed February 4, 2026 ...
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results